title: CK19 testing prior to OSNA analysis: to stain or not to stain?
authors.forename: Dionysios D
authors.initials: DD
authors.lastname: Remoundos
authors.forename: Meera
authors.initials: M
authors.lastname: Joshi
authors.forename: Farid
authors.initials: F
authors.lastname: Ahmed
authors.forename: Yoon
authors.initials: Y
authors.lastname: Chia
authors.forename: Giles H
authors.initials: GH
authors.lastname: Cunnick
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism*; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000378:metabolism; D018270:Carcinoma, Ductal, Breast / Q000175:diagnosis* / Q000378:metabolism / Q000556:secondary; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000378:metabolism / Q000473:pathology; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D053539:Keratin-19 / Q000378:metabolism*; D008198:Lymph Nodes / Q000378:metabolism / Q000473:pathology; D008207:Lymphatic Metastasis; D061206:Neoplasm Micrometastasis / Q000175:diagnosis; D021141:Nucleic Acid Amplification Techniques; D021701:Sentinel Lymph Node Biopsy; D013194:Staining and Labeling / Q000379:methods*
chemical_list: D014408:Biomarkers, Tumor; D053539:Keratin-19